CELGENE CORPORATION v. HETERO LABS LIMITED et al > Summary
Court Case Number 2:18-cv-17463
Filing Date Dec 20, 2018
Termination Date Jan 11, 2021
Court New Jersey District Court
Status Dismissed - Other
JudgesSusan D. Wigenton, Leda D. Wettre
Plaintiff
Defendant
Plaintiff Attorneys
14Celgene
Attorney Name: William C. Baton
Saul Ewing LLP
Celgene
Attorney Name: Frank C. Calvosa
Quinn Emanuel Urquhart & Sullivan
Celgene
Attorney Name: Brian Forsatz
Quinn Emanuel Urquhart & Sullivan
Celgene
Attorney Name: Charles M. Lizza
Saul Ewing LLP
Celgene
Attorney Name: David Leigh Moses
Saul Ewing LLP
Celgene
Attorney Name: Sarah A. Sullivan
Saul Ewing LLP
Celgene
Attorney Name: Evangeline L. Shih
Quinn Emanuel Urquhart & Sullivan
Celgene
Attorney Name: Eric C. Stops
Quinn Emanuel Urquhart & Sullivan
Celgene
Attorney Name: Gabriel P. Brier
Quinn Emanuel Urquhart & Sullivan
Celgene
Attorney Name: Cary Miller
Jones Day
Celgene
Attorney Name: Matthew J. Hertko
Jones Day
Celgene
Attorney Name: Andrew S. Chalson
Quinn Emanuel Urquhart & Sullivan
Celgene
Attorney Name: Dominic Cerrito
Quinn Emanuel Urquhart & Sullivan
Celgene
Attorney Name: Marta A. Godecki
Quinn Emanuel Urquhart & Sullivan
Defendant Attorneys
6Hetero
Attorney Name: Eric I. Abraham
Hill Wallack LLP
Hetero
Attorney Name: Bethany A. Corbin
Wiley Rein LLP
Hetero
Attorney Name: Christina Saveriano
Hill Wallack LLP
Hetero
Attorney Name: Yevgenia Shtilman Kleiner
Hill Wallack LLP
Hetero
Attorney Name: Neal Seth
Wiley Rein LLP
Hetero
Attorney Name: Wesley E. Weeks
Wiley Rein LLP
Cause
15:1126 Patent Infringement
Related Patents
Doc No | Title | Issue date |
---|---|---|
08741929 | Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of mantle cell lymphomas | Jun 3, 2014 |
07855217 | Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione | Dec 21, 2010 |
07468363 | Methods for treatment of cancers using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione | Dec 23, 2008 |
07465800 | Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione | Dec 16, 2008 |